Domain-swapped structure of a mutant of cyanovirin-N
- 28 May 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 294 (1) , 184-190
- https://doi.org/10.1016/s0006-291x(02)00455-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cyanovirin-N Defines a New Class of Antiviral Agent Targeting N-Linked, High-Mannose Glycans in an Oligosaccharide-Specific MannerMolecular Pharmacology, 2001
- Cyanovirin-N, a Potent Human Immunodeficiency Virus-Inactivating Protein, Blocks both CD4-Dependent and CD4-Independent Binding of Soluble gp120 (sgp120) to Target Cells, Inhibits sCD4-Induced Binding of sgp120 to Cell-Associated CXCR4, and Dissociates Bound sgp120 from Target CellsAntimicrobial Agents and Chemotherapy, 2001
- Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infectionMedicinal Research Reviews, 2000
- Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped VirusesJournal of Virology, 2000
- Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swappingJournal of Molecular Biology, 1999
- Solution structure of cyanovirin-N, a potent HIV-inactivating proteinNature Structural & Molecular Biology, 1998
- Mechanism and evolution of protein dimerizationProtein Science, 1998
- Analysis of Sequence Requirements for Biological Activity of Cyanovirin-N, a Potent HIV(Human Immunodeficiency Virus)-Inactivating ProteinBiochemical and Biophysical Research Communications, 1997
- Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide developmentAntimicrobial Agents and Chemotherapy, 1997
- Oligomer Formation By 3D Domain Swapping: A Model For Protein Assembly And MisassemblyAdvances in Protein Chemistry, 1997